Notice: This company has been marked as potentially delisted and may not be actively trading. Cleveland BioLabs (CBLI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CBLI vs. SCPS, EVLO, CMRA, ARDS, STAB, CALA, EFTR, ONCSQ, AEHAW, and CLVRShould you be buying Cleveland BioLabs stock or one of its competitors? The main competitors of Cleveland BioLabs include Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Calithera Biosciences (CALA), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), Aesther Healthcare Acquisition (AEHAW), and Clever Leaves (CLVR). Cleveland BioLabs vs. Scopus BioPharma Evelo Biosciences Comera Life Sciences Aridis Pharmaceuticals Statera Biopharma Calithera Biosciences eFFECTOR Therapeutics OncoSec Medical Aesther Healthcare Acquisition Clever Leaves Cleveland BioLabs (NASDAQ:CBLI) and Scopus BioPharma (NASDAQ:SCPS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Does the media refer more to CBLI or SCPS? In the previous week, Cleveland BioLabs' average media sentiment score of 0.00 equaled Scopus BioPharma'saverage media sentiment score. Company Overall Sentiment Cleveland BioLabs Neutral Scopus BioPharma Neutral Which has higher valuation & earnings, CBLI or SCPS? Cleveland BioLabs has higher revenue and earnings than Scopus BioPharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCleveland BioLabs$260K0.00-$2.40MN/AN/AScopus BioPharmaN/AN/A-$11.61MN/AN/A Does the MarketBeat Community believe in CBLI or SCPS? Cleveland BioLabs received 274 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 56.56% of users gave Cleveland BioLabs an outperform vote. CompanyUnderperformOutperformCleveland BioLabsOutperform Votes27656.56% Underperform Votes21243.44% Scopus BioPharmaOutperform Votes2100.00% Underperform VotesNo Votes Which has more risk and volatility, CBLI or SCPS? Cleveland BioLabs has a beta of 0.7, meaning that its share price is 30% less volatile than the S&P 500. Comparatively, Scopus BioPharma has a beta of -0.21, meaning that its share price is 121% less volatile than the S&P 500. Do insiders and institutionals have more ownership in CBLI or SCPS? 5.1% of Cleveland BioLabs shares are held by institutional investors. 1.0% of Cleveland BioLabs shares are held by insiders. Comparatively, 5.1% of Scopus BioPharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is CBLI or SCPS more profitable? Scopus BioPharma's return on equity of 0.00% beat Cleveland BioLabs' return on equity.Company Net Margins Return on Equity Return on Assets Cleveland BioLabsN/A -32.84% -31.29% Scopus BioPharma N/A N/A N/A SummaryCleveland BioLabs beats Scopus BioPharma on 5 of the 9 factors compared between the two stocks. Ad WealthPressDespite the Tesla Crash, These Traders Are 9 for 9Most Tesla shareholders are disappointed in the stock's performance in 2024, with a 30% decline year to date. But not this guy… One trader has found a way to turn Tesla’s downfall into a flurry of opportunity. In fact, he hasn’t lost a single trade on Tesla this year! See for yourself (Notice how short of a time period he holds onto the stock):*Get Access To the Free Training Here!* Get Cleveland BioLabs News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLI vs. The Competition Export to ExcelMetricCleveland BioLabsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$6.62B$5.23B$9.02BDividend YieldN/A2.91%5.30%4.18%P/E RatioN/A10.5287.8517.26Price / SalesN/A202.381,096.08147.61Price / CashN/A57.1143.3337.89Price / BookN/A5.175.195.13Net Income-$2.40M$153.18M$121.58M$227.03M Cleveland BioLabs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLICleveland BioLabsN/AN/AN/AN/A$5,000.00$260,000.000.004SCPSScopus BioPharmaN/A$0.00flatN/A-99.3%$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-99.0%$9,000.00N/A0.00120CMRAComera Life SciencesN/A$0.00flatN/A-99.7%$6,000.00$1.00M0.002ARDSAridis PharmaceuticalsN/A$0.00flatN/A-99.8%$5,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00flatN/AN/A$5,000.00$1.49M0.0020CALACalithera BiosciencesN/A$0.00flatN/A-99.0%$1,000.00$9.75M0.0060EFTReFFECTOR Therapeutics1.0319 of 5 stars$0.00-66.7%$24.00+11,999,900.0%-100.0%$1,000.00$3.55M0.0010Gap DownHigh Trading VolumeONCSQOncoSec MedicalN/AN/AN/AN/A$1,000.00N/A0.0040AEHAWAesther Healthcare AcquisitionN/A$0.03-2.7%N/A+11.8%$0.00N/A0.002Gap UpHigh Trading VolumeCLVRClever LeavesN/A$0.00flatN/A-100.0%$0.00$17.42M0.00560 Related Companies and Tools Related Companies Scopus BioPharma Alternatives Evelo Biosciences Alternatives Comera Life Sciences Alternatives Aridis Pharmaceuticals Alternatives Statera Biopharma Alternatives Calithera Biosciences Alternatives eFFECTOR Therapeutics Alternatives OncoSec Medical Alternatives Aesther Healthcare Acquisition Alternatives Clever Leaves Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CBLI) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cleveland BioLabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cleveland BioLabs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
